Global and United States Neuropathic Pain Drugs Market Report & Forecast 2024-2031

Report ID: 1860739 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Neuropathic Pain Drugs Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Neuropathic Pain Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Neuropathic Pain Drugs Market Size for the Year 2017-2028
        1.2.2 Global Neuropathic Pain Drugs Market Size for the Year 2017-2028
    1.3 Neuropathic Pain Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Neuropathic Pain Drugs in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Neuropathic Pain Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Neuropathic Pain Drugs Market Dynamics
        1.4.1 Neuropathic Pain Drugs Industry Trends
        1.4.2 Neuropathic Pain Drugs Market Drivers
        1.4.3 Neuropathic Pain Drugs Market Challenges
        1.4.4 Neuropathic Pain Drugs Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Neuropathic Pain Drugs by Type
    2.1 Neuropathic Pain Drugs Market Segment by Type
        2.1.1 Tricyclic Anti-Depressants Anticonvulsants
        2.1.2 Serotonin-Norepinephrine Reuptake Inhibitor
        2.1.3 Capsaicin Cream
        2.1.4 Local Anaesthesia
        2.1.5 Opioids
        2.1.6 Steroids
        2.1.7 Others
    2.2 Global Neuropathic Pain Drugs Market Size by Type (2017, 2022 & 2028)
    2.3 Global Neuropathic Pain Drugs Market Size by Type (2017-2028)
    2.4 United States Neuropathic Pain Drugs Market Size by Type (2017, 2022 & 2028)
    2.5 United States Neuropathic Pain Drugs Market Size by Type (2017-2028)
3 Neuropathic Pain Drugs by Application
    3.1 Neuropathic Pain Drugs Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Neuropathic Pain Drugs Market Size by Application (2017, 2022 & 2028)
    3.3 Global Neuropathic Pain Drugs Market Size by Application (2017-2028)
    3.4 United States Neuropathic Pain Drugs Market Size by Application (2017, 2022 & 2028)
    3.5 United States Neuropathic Pain Drugs Market Size by Application (2017-2028)
4 Global Neuropathic Pain Drugs Competitor Landscape by Company
    4.1 Global Neuropathic Pain Drugs Market Size by Company
        4.1.1 Top Global Neuropathic Pain Drugs Companies Ranked by Revenue (2021)
        4.1.2 Global Neuropathic Pain Drugs Revenue by Player (2017-2022)
    4.2 Global Neuropathic Pain Drugs Concentration Ratio (CR)
        4.2.1 Neuropathic Pain Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Neuropathic Pain Drugs in 2021
        4.2.3 Global Neuropathic Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Neuropathic Pain Drugs Headquarters, Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Neuropathic Pain Drugs Headquarters and Area Served
        4.3.2 Global Neuropathic Pain Drugs Companies Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Neuropathic Pain Drugs Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Neuropathic Pain Drugs Market Size by Company
        4.5.1 Top Neuropathic Pain Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Neuropathic Pain Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Neuropathic Pain Drugs Market Size by Region
    5.1 Global Neuropathic Pain Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Neuropathic Pain Drugs Market Size by Region (2017-2028)
        5.2.1 Global Neuropathic Pain Drugs Market Size by Region: 2017-2022
        5.2.2 Global Neuropathic Pain Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Neuropathic Pain Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Neuropathic Pain Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Neuropathic Pain Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Neuropathic Pain Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Neuropathic Pain Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Neuropathic Pain Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Neuropathic Pain Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Neuropathic Pain Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Neuropathic Pain Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Neuropathic Pain Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Neuropathic Pain Drugs Introduction
        7.1.4 Pfizer Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Company Details
        7.2.2 Johnson & Johnson Business Overview
        7.2.3 Johnson & Johnson Neuropathic Pain Drugs Introduction
        7.2.4 Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.2.5 Johnson & Johnson Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Company Details
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Neuropathic Pain Drugs Introduction
        7.3.4 Sanofi Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.3.5 Sanofi Recent Development
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Company Details
        7.4.2 GlaxoSmithKline Business Overview
        7.4.3 GlaxoSmithKline Neuropathic Pain Drugs Introduction
        7.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.4.5 GlaxoSmithKline Recent Development
    7.5 Eli Lilly
        7.5.1 Eli Lilly Company Details
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Neuropathic Pain Drugs Introduction
        7.5.4 Eli Lilly Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.5.5 Eli Lilly Recent Development
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Company Details
        7.6.2 Bristol-Myers Squibb Business Overview
        7.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Introduction
        7.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.6.5 Bristol-Myers Squibb Recent Development
    7.7 Biogen
        7.7.1 Biogen Company Details
        7.7.2 Biogen Business Overview
        7.7.3 Biogen Neuropathic Pain Drugs Introduction
        7.7.4 Biogen Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.7.5 Biogen Recent Development
    7.8 Baxter Healthcare
        7.8.1 Baxter Healthcare Company Details
        7.8.2 Baxter Healthcare Business Overview
        7.8.3 Baxter Healthcare Neuropathic Pain Drugs Introduction
        7.8.4 Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.8.5 Baxter Healthcare Recent Development
    7.9 Depomed
        7.9.1 Depomed Company Details
        7.9.2 Depomed Business Overview
        7.9.3 Depomed Neuropathic Pain Drugs Introduction
        7.9.4 Depomed Revenue in Neuropathic Pain Drugs Business (2017-2022)
        7.9.5 Depomed Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Neuropathic Pain Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Neuropathic Pain Drugs Market Trends
    Table 3. Neuropathic Pain Drugs Market Drivers
    Table 4. Neuropathic Pain Drugs Market Challenges
    Table 5. Neuropathic Pain Drugs Market Restraints
    Table 6. Global Neuropathic Pain Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Neuropathic Pain Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Neuropathic Pain Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Neuropathic Pain Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Neuropathic Pain Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Neuropathic Pain Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Neuropathic Pain Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Neuropathic Pain Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neuropathic Pain Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Drugs as of 2021)
    Table 15. Top Players of Neuropathic Pain Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Neuropathic Pain Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Neuropathic Pain Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Neuropathic Pain Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Neuropathic Pain Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Neuropathic Pain Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Neuropathic Pain Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Neuropathic Pain Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Neuropathic Pain Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Neuropathic Pain Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Neuropathic Pain Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Neuropathic Pain Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Neuropathic Pain Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Neuropathic Pain Drugs Product
    Table 33. Pfizer Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Johnson & Johnson Company Details
    Table 36. Johnson & Johnson Business Overview
    Table 37. Johnson & Johnson Neuropathic Pain Drugs Product
    Table 38. Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 39. Johnson & Johnson Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Neuropathic Pain Drugs Product
    Table 43. Sanofi Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. GlaxoSmithKline Company Details
    Table 46. GlaxoSmithKline Business Overview
    Table 47. GlaxoSmithKline Neuropathic Pain Drugs Product
    Table 48. GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 49. GlaxoSmithKline Recent Development
    Table 50. Eli Lilly Company Details
    Table 51. Eli Lilly Business Overview
    Table 52. Eli Lilly Neuropathic Pain Drugs Product
    Table 53. Eli Lilly Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 54. Eli Lilly Recent Development
    Table 55. Bristol-Myers Squibb Company Details
    Table 56. Bristol-Myers Squibb Business Overview
    Table 57. Bristol-Myers Squibb Neuropathic Pain Drugs Product
    Table 58. Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 59. Bristol-Myers Squibb Recent Development
    Table 60. Biogen Company Details
    Table 61. Biogen Business Overview
    Table 62. Biogen Neuropathic Pain Drugs Product
    Table 63. Biogen Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 64. Biogen Recent Development
    Table 65. Baxter Healthcare Company Details
    Table 66. Baxter Healthcare Business Overview
    Table 67. Baxter Healthcare Neuropathic Pain Drugs Product
    Table 68. Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 69. Baxter Healthcare Recent Development
    Table 70. Depomed Company Details
    Table 71. Depomed Business Overview
    Table 72. Depomed Neuropathic Pain Drugs Product
    Table 73. Depomed Revenue in Neuropathic Pain Drugs Business (2017-2022) & (US$ Million)
    Table 74. Depomed Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuropathic Pain Drugs Product Picture
    Figure 2. Global Neuropathic Pain Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Neuropathic Pain Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Neuropathic Pain Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Neuropathic Pain Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Neuropathic Pain Drugs Market Share in Global 2017-2028
    Figure 7. Neuropathic Pain Drugs Report Years Considered
    Figure 8. Product Picture of Tricyclic Anti-Depressants Anticonvulsants
    Figure 9. Product Picture of Serotonin-Norepinephrine Reuptake Inhibitor
    Figure 10. Product Picture of Capsaicin Cream
    Figure 11. Product Picture of Local Anaesthesia
    Figure 12. Product Picture of Opioids
    Figure 13. Product Picture of Steroids
    Figure 14. Product Picture of Others
    Figure 15. Global Neuropathic Pain Drugs Market Share by Type in 2022 & 2028
    Figure 16. Global Neuropathic Pain Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global Neuropathic Pain Drugs Market Share by Type (2017-2028)
    Figure 18. United States Neuropathic Pain Drugs Market Share by Type in 2022 & 2028
    Figure 19. United States Neuropathic Pain Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States Neuropathic Pain Drugs Market Share by Type (2017-2028)
    Figure 21. Product Picture of Hospital Pharmacies
    Figure 22. Product Picture of Retail Pharmacies
    Figure 23. Product Picture of Online Pharmacies
    Figure 24. Global Neuropathic Pain Drugs Market Share by Application in 2022 & 2028
    Figure 25. Global Neuropathic Pain Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Neuropathic Pain Drugs Market Share by Application (2017-2028)
    Figure 27. United States Neuropathic Pain Drugs Market Share by Application in 2022 & 2028
    Figure 28. United States Neuropathic Pain Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Neuropathic Pain Drugs Market Share by Application (2017-2028)
    Figure 30. North America Neuropathic Pain Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Neuropathic Pain Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Neuropathic Pain Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Neuropathic Pain Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Neuropathic Pain Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. UAE Neuropathic Pain Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 62. Eli Lilly Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 64. Biogen Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 65. Baxter Healthcare Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 66. Depomed Revenue Growth Rate in Neuropathic Pain Drugs Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Frequently Asked Questions
Neuropathic Pain Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuropathic Pain Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuropathic Pain Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Neurotechnology

Neurotechnology market is segmented by region (country), players, by Type and by Application. Pla ... Read More